Skip to main content
TTrialFinderData
TrialFinderData is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Anaplastic Thyroid Cancer Clinical Trials

Reviewed by TrialFinderData Editorial Team · Updated

2 recruiting trials for Anaplastic Thyroid Cancer. Eligibility criteria explained in plain English.

TrialFinderData lists 2 Anaplastic Thyroid Cancer clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.

Every phased trial in this set is Phase 2 (2 of the listed studies); the remaining records are observational or have no phase recorded on ClinicalTrials.gov.

The only sponsor on record for these trials is Saint Petersburg State University, Russia (2 trials).

The most frequently studied intervention is Dabrafenib + Trametinib (drug, 1 trial), followed by Pembrolizumab + Lenvatinib.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
2
Total Trials
2
Recruiting Now
0
Phase 3 Trials
1
Sponsors

Track Anaplastic Thyroid Cancer trials

Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.

Recruiting Trials

Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.

RECRUITINGPhase 2NCT06362694

Study of the Rechallenge Concept in Patients With BRAF-positive Anaplastic Thyroid Cancer After Progression on...

This pilot phase 2 study evaluates the effectiveness and safety of the Rechallenge concept in patients with BRAF-positive anaplastic thyroid cancer after progression on anti-BRAF...

Sponsor: Saint Petersburg State University, RussiaEnrolling: 101 location
RECRUITINGPhase 2NCT06374602

Efficacy of Pembrolizumab and Lenvatinib in Patients With Anaplastic Thyroid Cancer

This pilot phase 2 study evaluate the effectiveness and safety of pembrolizumab and lenvatinib in patients with anaplastic thyroid cancer. Patients with anaplastic thyroid cancer...

Sponsor: Saint Petersburg State University, RussiaEnrolling: 201 location

Explore Other Conditions

Obesity, 139 recruiting
Breast Cancer, 137 recruiting
Lung Cancer, 132 recruiting
Stroke, 131 recruiting

Frequently Asked Questions

There are currently 2 clinical trials for Anaplastic Thyroid Cancer, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.

To join a clinical trial for Anaplastic Thyroid Cancer, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.

Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Anaplastic Thyroid Cancer, representing treatments closest to potential FDA approval.

Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.

Sources: ClinicalTrials.gov, FDA
Last updated:

Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.